StockTipsArenaBeta

Acutaas Chemicals Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹3,152.4-101.00 (-3.10%)
As of 21 Oct 2026

Avg 1-year target

All 3 long-term calls are BUY

₹3,850.3322.1% above today's price

Acutaas Chemicals' average 1-year share price target is ₹3,850.33, the average of 3 advisors' latest targets. Targets range from ₹3,750 to ₹4,001.

Latest: Vikas Sethi, Sethi Finmart ₹3,750 · 19 Oct 2026

3
3 BUY · 0 SELL, all horizons
3
with an active 1Y target
53%
8 of 15 closed calls hit
19
all horizons, open and closed
Watch ACUTAAS for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Acutaas Chemicals target price by brokerage

Each advisor's latest 1-year target · 3 advisors · tap a row for the call

All tips (19)

BUYTarget₹3,750
VSbyVikas Sethi, Sethi Finmart+19.0% to target
1 Year · 12 mo left · 19 Oct 2026 · entry ₹3,307.3 · via Zee Business (Live)P&L -4.7%
BUYTarget₹3,800
JFbyJM Financial+20.5% to target
1 Year · 11 mo left · 10 Sept 2026 · entry ₹3,451.25 · via LiveMint MarketsP&L -8.7%
BUYTarget₹4,001
ICbyIDBI Capital+26.9% to target
1 Year* · 9 mo left · 27 Jul 2026 · entry ₹3,367.8 · via Institutional / Brokerage ResearchP&L -6.4%
BUYTarget₹3,001
ICbyIDBI CapitalTarget hit
1 Year* · 4 May 2026 · entry ₹2,676.4 · via Institutional / Brokerage Researchexit ₹3,001
BUYTarget₹2,501
ICbyIDBI CapitalTarget hit
1 Year* · 29 Jan 2026 · entry ₹1,934.1 · via Institutional / Brokerage Researchexit ₹2,501
BUYTarget₹2,350
GFbyGeojit Financial ServicesTarget hit
1 Year* · 29 Jan 2026 · entry ₹1,934.1 · via Institutional / Brokerage Researchexit ₹2,350
BUYTarget₹2,141
ICbyIDBI CapitalTarget hit
1 Year* · 23 Oct 2025 · entry ₹1,740.2 · via Institutional / Brokerage Researchexit ₹2,141
BUYTarget₹1,405
ICbyIDBI CapitalTarget hit
1 Year* · 31 Jul 2025 · entry ₹1,327.4 · via Institutional / Brokerage Researchexit ₹1,405
BUYTarget₹1,385
DCbyDeven Choksey, DRChokseyTarget hit
1 Year* · 24 Jul 2025 · entry ₹1,187.2 · via Institutional / Brokerage Researchexit ₹1,385
BUYTarget₹1,368
ICbyIDBI CapitalTarget hit
1 Year* · 7 May 2025 · entry ₹1,146.4 · via Institutional / Brokerage Researchexit ₹1,368
BUYTarget₹2,250⚙︎
ICbyIDBI CapitalTarget hit
1 Year* · 30 Oct 2024 · entry ₹1,919.25 · via Institutional / Brokerage Researchexit ₹2,250
BUYTarget₹3,815
ICbyIDBI CapitalStop-loss hit
1–3 Months* · 18 Sept 2026 · entry ₹3,455 · via IDBI Capital Research Calls Telegramexit ₹3,300
BUYTarget₹4,300
MIbyMarketSmith IndiaStop-loss hit
1–3 Months · 11 Sept 2026 · entry ₹3,450 · via LiveMint Marketsexit ₹3,190
BUYTarget₹3,534
AKbyArun Kumar MantriStop-loss hit
1–2 Weeks* · 19 Oct 2026 · entry ₹3,308 · via CNBC Awaaz.exit ₹3,202
BUYTarget₹3,550
AKbyArun Kumar MantriStop-loss hit
1–2 Weeks* · 21 Sept 2026 · entry ₹3,465.7 · via CNBC Awaaz.exit ₹3,437
BUYTarget₹3,493
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 27 Aug 2026 · entry ₹3,326 · via IDBI Capital Research Calls Telegramexit ₹3,243
BUYTarget₹3,495
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 18 Aug 2026 · entry ₹3,295 · via IDBI Capital Research Calls Telegramexit ₹3,190
BUYTarget₹3,850
RBbyRajesh Bhosale, Angel One○ No trade
1–2 Weeks* · 19 Aug 2026 · entry ₹3,400 · via NDTV Profit
BUYTarget₹3,507
AJbyAnsh Jogendra BhilwarExpired
Intraday · 30 Sept 2026 · entry ₹3,334.1 · via Zee Business (Live)exit ₹3,278.7

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks